| HOME >> MEDICINE >> TECHNOLOGY |
Market Evaluation for Drug Discovery in Epigenetics
Research 48
TABLE 15 GLOBAL MARKET FOR RESEARCH AND DRUG
DISCOVERY IN EPIGENTICS, THROUGH 2017 ($ BILLIONS) 49
TABLE 16 SALES OF FOUR EPIGENETIC DRUGS, 2009–2011 ($
MILLIONS) 50
SUMMARY AND EVALUATION OF GENOMICS-BASED DRUG
DISCOVERY TECHNOLOGY MARKET 51
TABLE 17 GLOBAL MARKET FOR GENOMICS-BASED DRUG
DISCOVERY PLATFORMS, THROUGH 2017 ($ BILLIONS) 51
CHAPTER FIVE: PROTEOMICS RESEARCH AS A DRUG DISCOVERY
TECHNOLOGY AND PLATFORM 52
OVERVIEW 52
PROTEOMICS TECHNOLOGIES THE IN DRUG DISCOVERY
MARKET 53
PROTEIN ISOLATION AND IDENTIFICATION
TECHNOLOGY FOR BIOMARKER OR DRUG TARGET
DISCOVERY 53
Size Exclusion Chromatography 54
Separation Based on Charge or Hydrophobicity 54
Affinity Chromatography 55
Immunoaffinity Chromatography 55
High-Performance Liquid Chromatography as One of the
Main Technologies in Proteomics Drug Discovery 55
High-Performance Liquid (Continued) 56
Sample Injectors 57
Pumps 57
Columns 57
TABLE 18 GLOBAL HIGH-PERFORMANCE (OR HIGH-PRESSURE)
LIQUID CHROMATOGRAPHY (HPLC) MARKET, THROUGH 2017 ($
BILLIONS) 58
TABLE 19 PERCENTAGE OF CUSTOMER DISTRIBUTION IN
COLUMN SEPARATION MARKET IN 2011 59
PROTEIN IDENTIFICATION AND CHARACTERIZATION
TECHNIQUES IN PROTEOMICS DRUG DISCOVERY 59
Mass Spectrometry and the Drug Discovery Sector 59
Mass Spectrometry Instruments 60
Ionization Procedure 60
Matrix-Assisted Laser Desorption/Ionization
(MALDI) 61
Electrospray Ionization (ESI) 61
Atmospheric Pressure Chemical Ionization
(APCI) 61
Mass Analyzers 62
Quadrupole 62
Time-of-Flight Mass Spectrometry 62
Quadrupole—Time-of-Flight (Q-TOF) 63
Ion Trap Mass Spectroscopy 63
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |